| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 10/01/2002 | US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 10/01/2002 | US6458785 Aids therapy |
| 10/01/2002 | US6458772 Prodrugs |
| 09/27/2002 | CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/26/2002 | WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) |
| 09/26/2002 | WO2002074760A1 Production of 5-methylbutyrolactone from levulinic acid |
| 09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | WO2002074757A1 Method for producing substituted pyrroles and furans |
| 09/26/2002 | WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | WO2002074718A2 Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137954 Process for preparing metal ascorbate and its precursor |
| 09/26/2002 | US20020137950 Disodium(2S,3S)-tetrahydro-3-hydroxy-5-oxo-2,3-furandicarboxylate for example, as well as corresponding acyl halides, esters, cyclic imides, and protected hydroxyl derivates thereof |
| 09/26/2002 | US20020137947 Inhibits alpha v integrins; treating tumors or cancer |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137881 Esters of 3-(2-furyl)-2propenoic acid with diols |
| 09/26/2002 | US20020137750 Amidine derivatives which are inhibitors of nitric oxide synthase |
| 09/26/2002 | US20020137736 Novel compounds |
| 09/26/2002 | DE10114084A1 New 1,3-diamino-4-aminomethyl-benzene derivatives, useful as coupler substances in oxidative hair dye formulations based on a developer-coupler combination |
| 09/26/2002 | DE10112068A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
| 09/26/2002 | CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | CA2437740A1 Production of 5-methylbutyrolactone from levulinic acid |
| 09/25/2002 | EP1242410A1 Novel compounds |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/25/2002 | EP1242390A1 Method for production of 1,3-disubstituted 2-nitroguanidines |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242367A1 2-[3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 09/25/2002 | EP1242366A1 Salicylamides as serine protease and factor xa inhibitors |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1242354A1 Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride |
| 09/25/2002 | EP1242352A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 09/25/2002 | EP1242059A2 Novel prodrugs for antimicrobial amidines |
| 09/25/2002 | EP1212310A4 Production of maleic anhydride |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | CN1370775A Refining process of electron level oxydiphenyl diformic anhydride |
| 09/25/2002 | CN1370774A Butylene oxide recovering process |
| 09/25/2002 | CN1370405A Aryl hydrazide compound with activity of inhibiting growth of mosqito larva |
| 09/25/2002 | CN1091397C Process for transformation of vanadium/phophorus mixed oxide catalyst precursor into active catalyst for production of maleic anhydride |
| 09/24/2002 | US6455710 Method for the preparation of pure citalopram |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455545 Gastrointestinal disorders |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/19/2002 | WO2002072568A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 09/19/2002 | WO2002072565A1 Process for the preparation of citalopram |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072553A1 Antiproliferative agents |
| 09/19/2002 | WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands. |
| 09/19/2002 | WO2002072545A2 9-aminoacyl tetracycline compounds and methods of use thereof |
| 09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
| 09/19/2002 | WO2002072530A1 Permanent surface modifiers |
| 09/19/2002 | WO2002072505A1 Optical resolver and method of optically resolving alcohol with the same |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133028 Perfumes |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132783 E.g., beta-1'-nicotinamide-2'-deoxyribose, beta-D-1'-nicotinamide-2'-deoxyribofuranoside, beta -1'-pyridyl-2'-deoxyribose, or 5'-phospho-1'-pyridyl-deoxyribose. |
| 09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
| 09/19/2002 | DE10111065A1 Verbessertes Verfahren zur Herstellung von ungesättigten cyclischen Ethern An improved process for preparing unsaturated cyclic ethers |
| 09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2439856A1 Process for the preparation of citalopram |
| 09/19/2002 | CA2439221A1 Permanent surface modifiers |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/18/2002 | EP1241160A1 Tetracycline derivatives and their use as antibiotic agents |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240130A1 Method for oxidation of xylene derivatives |
| 09/18/2002 | EP1239886A2 Labelled ascorbic acid derivatives |
| 09/18/2002 | EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 09/18/2002 | EP0922022B1 Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran |
| 09/18/2002 | EP0891962B1 Process for the preparation of fluorinated dicarbonyl compounds |
| 09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/18/2002 | EP0874839B1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370168A Novel spiro compounds |
| 09/18/2002 | CN1370157A Prepn. and use of gamma-butyrolactones as cross-linking agents |
| 09/18/2002 | CN1370139A Method for producing phthallic anhydride according to specifications |
| 09/18/2002 | CN1369485A Process for extracting and refining tanshinone IIA by supercritical CO2 |
| 09/18/2002 | CN1369476A Process for prepn. of cyclopropane formic ether |
| 09/17/2002 | US6452044 Benzenedicarboxylic acid derivatives |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451849 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 09/17/2002 | US6451845 Antidiabetic agents |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |